New drug trial aims to slow Parkinson's progression
Disease control
Not yet recruiting
This study is testing an investigational drug called FHL-301 in adults with early-stage Parkinson's disease. It aims to see if the drug is safe, well-tolerated, and can help control the movement symptoms of the disease. Participants will be randomly assigned to receive either FHL…
Phase: PHASE2 • Sponsor: Forest Hills Lab • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC